Clinical trial software for Basel biotech

The Basel area around the Rhine, with the neighbouring French and German borders, is one of Europe’s densest life-science regions. The two big anchors set the tone: high expectations for data quality, a lot of experienced clinical staff who move between large and small companies, and a service ecosystem that is used to enterprise tools. For a founder with a Phase 1 asset and a team of ten, that is both an advantage and a pressure. Investors and partners expect a clean, traceable dataset from the first participant, but the company has neither the budget nor the time for the platform a large sponsor would buy.

A self-serve system meets that expectation differently. Instead of a vendor-led implementation, you upload the protocol, review an AI draft of visits and forms, add edit checks and calculated fields, and test in the sandbox with your first site. The audit trail is field-level and append-only, and the same system carries consent and patient-reported outcomes. For a founder’s perspective see clinical trial software for biotech founders, and for study-type specifics EDC for first-in-human studies and clinical trial software for early-phase trials.

Many Basel sponsors also work across borders. A trial with sites in Basel, Freiburg and Strasbourg touches three legal systems, which makes a single study with site-level access, coded IDs and by-site exports a practical way to keep the data coherent while ethics and regulatory approvals remain local.

For clinical trials of medicinal products in Switzerland, Swissmedic authorises the trial and the cantonal ethics committee responsible for the site gives its own approval. Swissmedic’s published procedure describes a parallel review, and the clinical trial ordinances were revised with effect from 1 November 2024. Exact assessment timelines and categories depend on the type of trial, so use Swissmedic’s current guidance and your regulatory lead rather than a software vendor’s summary. Capture does not hold, and does not claim, any Swiss regulatory approval.

On data protection, Switzerland has its own Federal Act on Data Protection, revised in 2023, and the EU treats Switzerland as providing adequate protection for many transfers. If you also enrol participants in the EU, GDPR applies to that processing. Study data can be hosted in Frankfurt, with encryption at rest and in transit, coded participant IDs for researchers and name visibility limited to site coordinators. Read GDPR compliant clinical trial software and hipaa vs GDPR for the underlying design, and ask your data protection adviser how Swiss and EU rules combine for your study.

For EU sites in the same programme, EU CTR and clinical trial software and clinical trial software in Germany describe the other side of the border. The EMA computerised systems guideline is useful as a checklist of data-system expectations, even where it is not directly binding.